Robert L. Findling, MD, MBA
Robert L. Findling, MD, MBA
The Johns Hopkins University and Kennedy Kreiger Institute and The Johns Hopkins University/Kennedy Krieger Institute
- Consultant: Alexza Pharmaceuticals Inc.; American Academy of Child & Adolescent Psychiatry; Bracket; Bristol-Myers Squibb; Cognition Group; Coronado Biosciences; Dana Foundation; GlaxoSmithKline; Guilford Press; Hoffmann-La Roche Inc.; Jubilant Clinsys, Inc.; KemPharm, Inc.; Lundbeck Inc; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Physicians Postgraduate Press; Shire Pharmaceuticals, Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Transcept Pharmaceuticals, Inc.; Validus Holdings, Ltd.; WebMD, LLC.
- Grant Support: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson Services, Inc.; Lundbeck Inc; Merck & Co., Inc.; National Institutes of Health; Novartis Pharmaceutical Corporation; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Rhodes Pharmaceuticals L.P.; Shire Pharmaceuticals, Inc.; Stanley Medical Research Institute; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.
- Royalties: American Psychiatric Publishing; Johns Hopkins University Press; Oxford University Press; SAGE Pharma
- Speakers Bureau: American Physician Institute